Page last updated: 2024-08-26

racecadotril and sildenafil citrate

racecadotril has been researched along with sildenafil citrate in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Baliga, RS; Hobbs, AJ; Lopez-Torondel, B; MacAllister, RJ; Madhani, M; Selwood, D; Visintin, C; Wilkins, MR; Zhao, L1

Other Studies

2 other study(ies) available for racecadotril and sildenafil citrate

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Synergy between natriuretic peptides and phosphodiesterase 5 inhibitors ameliorates pulmonary arterial hypertension.
    American journal of respiratory and critical care medicine, 2008, Oct-15, Volume: 178, Issue:8

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Atrial Natriuretic Factor; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Hypertension, Pulmonary; Male; Neprilysin; Piperazines; Protease Inhibitors; Pulmonary Artery; Purines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones; Thiorphan; Treatment Outcome; Vascular Resistance; Vasodilation; Vasodilator Agents

2008